<DOC>
	<DOC>NCT00994461</DOC>
	<brief_summary>A study to confirm the superiority of celecoxib 100 mg BID to loxoprofen 60 mg TID in the incidence of gastroduodenal endoscopic ulcers after 2 weeks treatment.</brief_summary>
	<brief_title>Study Of Celecoxib In Healthy Subjects</brief_title>
	<detailed_description />
	<mesh_term>Loxoprofen</mesh_term>
	<mesh_term>Celecoxib</mesh_term>
	<criteria>Healthy Volunteers Endoscopic evidence of ulceration, erosion or active bleeding etc. in the esophagus, stomach, pylorus and/or duodenum prior to treatment endoscopy A history of gastrointestinal ulcer Any use of celecoxib, nonsteroidal antiinflammatory drugs (including aspirin), antiulcer medication, antacids, systemic steroids or antibiotics within four weeks prior to the first dose of study medication</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>74 Years</maximum_age>
	<verification_date>May 2011</verification_date>
	<keyword>Endoscopy</keyword>
</DOC>